Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts

American Journal of Pathology

Volumn 151, Issue 3, 1997, Pages 651-657

  Blazejewski, Sylvie ^a   Le Bail, Brigitte ^a   Boussarie, Liliane ^a   Blanc, Jean Frédéric ^a   Malaval, Luc ^b   Okubo, Kousaku ^c   Saric, Jean ^a   Bioulac Sage, Paulette ^a   Rosenbaum, Jean ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; OSTEONECTIN;

ARTICLE; CELL CULTURE; DNA LIBRARY; EXTRACELLULAR MATRIX; FIBRIN FORMATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LIVER FIBROSIS; LIVER SINUSOID; MYOFIBROBLAST; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY;

ACTINS; BLOTTING, NORTHERN; CELLS, CULTURED; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; LIVER CIRRHOSIS; OSTEONECTIN; RNA, MESSENGER;

EID: 0030982436     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR: Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981, 26:99-105
2. Clezardin P, Malaval L, Morel MC, Guichard J, Lecompte T, Trzeciak MC, Dechavanne M, Breton-Gorius J, Delmas PD, Kaplan C: Osteonectin is an α-granule component involved with trombospondin in platelet aggregation. J Bone Miner Res 1991, 6:1059-1070
3. 2+-dependent binding to the extracellular matrix. J Cell Biol 1989, 109:341-356
4. Goldblum SE, Ding X, Funk SE, Sage EH: SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci USA 1994, 91:3448-3452
5. Everitt EA, Sage EH: Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells. Exp Cell Res 1992, 199:134-146
6. 2+-deficient medium. Biochem Cell Biol 1992, 70:1368-1378
7. Friedman SL: The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993, 328:1828-1835
8. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH: The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 1992, 89:1281-1285
9. Pinzani M, Milani S, Herbst H, Defranco R, Grappone C, Gentilini A, Caligiuri A, Pellegrini G, Ngo DV, Romanelli RG, Gentilini P: Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 1996, 148:785-800
10. Win KM, Charlotte F, Cherqui D, Mavier P, Préaux AM, Dhumeaux D, Rosenbaum J: Mitogenic effect of transforming growth factor-β1 on human lto cells in culture: evidence for a mediation by endogenous platelet-derived growth factor. Hepatology 1993, 18:137-145
11. Hasselaar P, Sage EH: SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 1992, 49:272-283
12. Charlotte F, Win KM, Préaux AM, Mavier P, Dhumeaux D, Zafrani ES, Rosenbaum J: Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver: selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis. J Pathol 1993, 169: 471-476
13. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE: Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989, 84:1786-1793
14. Rosenbaum J, Mallat A, Préaux AM, Mavier P, Zafrani ES, Dhumeaux D: Effect of polypeptide growth factors on growth of cultured human hepatic myofibroblast-like cells (transformed lto cells). Cells of the hepatic sinusoid, vol 3. Edited by E Wisse, DL Knook, DJ McCuskey. Rijswijk, The Kupffer Cell Foundation, 1991, pp 255-258
15. Kamihagi K, Katayama M, Ouchi R, Kato I: Osteonectin/SPARC regulates cellular secretion rate of fibronectin and laminin extracellular matrix proteins. Biochem Biophys Res Commun 1994, 200:423-428
16. Tremble PM, Lane TF, Sage EH, Werb Z: SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 1993, 121:1433-1444
17. Hasselaar P, Loskutoff DJ, Sawdey M, Sage EH: SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells. J Biol Chem 1991, 266:13178-13184
18. Frizell E, Liu SH, Abraham A, Ozaki I, Eghbali M, Sage EH, Zern MA: Expression of SPARC in normal and fibrotic livers. Hepatology 1995, 21:847-854
19. Blazejewski S, Préaux AM, Mallat A, Mavier P, Dhumeaux D, Schuppan D, Rosenbaum J: Human myofibroblast-like cells obtained by outgrowth are representative of the fibrogenic cells in the liver. Hepatology 1995, 22:788-797
20. Okubo K, Hori N, Matoba R, Niyama T, Fukushima A, Kojima Y, Matsubara K: Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression. Nat Genet 1992, 2:173-179
21. Okubo K, Itoh K, Fukushima A, Yoshii J, Matsubara K: Monitoring cell physiology by expression profiles and discovering cell type-specific genes by compiled expression profiles. Genomics 1995, 30:178-186
22. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol extraction. Anal Biochem 1987, 162:156-159
23. Swaroop A, Hogan BLM, Francke U: Molecular analysis of the cDNA for human SPARC/osteonectin/BM 40: sequence, expression, and localization of the gene to chromosome 5q31-q33. Genomics 1988, 2:37-47
24. Rosenbaum J, Blazejewski S, Préaux AM, Mallat A, Dhumeaux D, Mavier P: Fibroblast growth factor 2 and transforming growth factor beta-1 interactions in human liver myofibroblasts. Gastroenterology 1995, 109:1986-1996
25. Malaval L, Darbouret B, Preaudat C, Jolu JP, Delmas PD: Intertissular variations in osteonectin: a monoclonal antibody directed to bone osteonectin shows reduced affinity for platelet osteonectin. J Bone Miner Res 1991, 6:315-323
26. Malaval L, Fournier B, Delmas PD: Radioimmunoassay for osteonectin: concentrations in bone, non mineralized tissues and blood. J Bone Miner Res 1977, 2:457-465
27. Fisher LW, Stubbs JT, Young MF: Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand 1995, 66(Suppl 266):1-5
28. Nischt R, Pottgiesser J, Krieg T, Mayer U, Aumailley M, Timpl R: Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur J Biochem 1991, 200:529-536
29. Lamas E, Le Bail B, Housset C, Boucher O, Bréchot C: Localization of insulin-like growth factor-II and hepatitis B virus mRNAs and proteins in human hepatocellular carcinomas. Lab Invest 1991, 64:98-104
30. Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol 1994, 125:929-943
31. Porter PL, Sage EH, Lane TF, Funk SE, Gown AM: Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 1995, 43:791-800
32. Kuhn C, Mason RJ: Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol 1995, 147:1759-1769